LAUNCHED this week at Achema is a new workstation for sterility testing, the Bioquell Qube, which will help laboratories in their increasingly-important sterilisation validation processes. Qube will help ensure that an aseptic test environment is properly controlled, in order to eliminate false positive results.
The device delivers sporicidal bio-decontamination using hydrogen peroxide vapour (HPV), resulting in a validated 6-log reduction in bioburden says Bioquell. It is intended to complement a fitted and validated sterility test unit such as the Millipore Steritest.
Qube physically separates operators from the test, enabling the use of automated HPV biological decontamination. Within a single module, a rapid 20 minute bio-decontamination cycle allows fast and efficient transfers. An EU GMP Grade A / ISO 5 compliant environment is ensured by both uni-directional airflow and unique isolator technology.
The modular design provides flexible configurations, so a single module can be installed where space is restricted, or a three-chamber workstation can be deployed for high volume throughput.